First AD

Second AD

Recent Advances in Endometrial Cancer

OncLive News Network®

® video programs provide lively discussions, insights, and expert perspectives on important issues facing today’s cancer care professionals. One variation of the program, titled, 

, comprises live virtual or on-site premium reporting for oncologists as it covers the latest news and information coming out of the largest annual oncology conferences. 

Gynecologic Oncology

CLO-22-OSD1210 - /clinical/gynecologic-oncology

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

Post-Conference Perspectives Year in Review: 2023 Developments in Advanced or Recurrent Endometrial Cancer

Matthew Powell, MD, and Floor Backes, MD, discuss recent advances in the molecular profiling and staging of endometrial cancer.

Key Takeaways From the 2023 Society of Gynecologic Oncology (SGO) Annual Meeting

Current Data on Single-Agent Immunotherapy in Advanced Endometrial Cancer

Dostarlimab Plus Chemotherapy for the Treatment of Advanced Endometrial Cancer: Data from the RUBY Trial

Data From the AtTEnd: Study: Atezolizumab Plus Carboplatin and Paclitaxel for Treatment of Advanced Endometrial Cancer

The Impact of Real-World Evidence on the Treatment of Patients With Advanced Endometrial Cancer

Adverse Events Seen With Systemic Therapies in Patients With Advanced Endometrial Cancer

The TROPiCS-03 Study: Sacituzumab Govitecan in Patients With Advanced Endometrial Cancer

Unmet Needs in the Management of Patients With Advanced Endometrial Cancer

Clinical Pearls for Community Oncologists Treating Patients With Advanced Endometrial Cancer